These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 19097521)
1. Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report. Hoekstra AV; Kim JJ; Keh P; Schink JC J Reprod Med; 2008 Nov; 53(11):869-73. PubMed ID: 19097521 [TBL] [Abstract][Full Text] [Related]
2. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer. Yang YC; Wu CC; Chen CP; Chang CL; Wang KL Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate. Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142 [TBL] [Abstract][Full Text] [Related]
4. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. Park JY; Nam JH Oncologist; 2015 Mar; 20(3):270-8. PubMed ID: 25673106 [TBL] [Abstract][Full Text] [Related]
5. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer. Hurst SA; Hartzfeld KM; Del Priore G Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366 [TBL] [Abstract][Full Text] [Related]
6. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures]. Wang HY; Shen L; Sun Z Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457 [TBL] [Abstract][Full Text] [Related]
7. Fertility-preserving treatment in young women with endometrial cancer. Böing C; Kimmig R Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):25-33. PubMed ID: 16452817 [TBL] [Abstract][Full Text] [Related]
8. Outcome of conservative treatment and subsequent assisted reproductive technology for patients with early-stage endometrial adenocarcinoma and poor fertility potential. Tong XM; Zhu HY; Lin XN; Jiang LY; Xu WH; Liu L; Zhang SY Chin Med J (Engl); 2012 Oct; 125(19):3578-80. PubMed ID: 23044328 [TBL] [Abstract][Full Text] [Related]
9. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer. Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726 [TBL] [Abstract][Full Text] [Related]
10. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Wang CB; Wang CJ; Huang HJ; Hsueh S; Chou HH; Soong YK; Lai CH Cancer; 2002 Apr; 94(8):2192-8. PubMed ID: 12001117 [TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate drives endometrial carcinoma cell senescence via interacting with progesterone receptor B/FOXO1 axis. Wang H; Shi H Exp Biol Med (Maywood); 2021 Nov; 246(21):2307-2316. PubMed ID: 34233525 [TBL] [Abstract][Full Text] [Related]
12. The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma. Utsunomiya H; Suzuki T; Ito K; Moriya T; Konno R; Sato S; Yaegashi N; Okamura K; Sasano H Clin Endocrinol (Oxf); 2003 Jun; 58(6):696-703. PubMed ID: 12780745 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Ota T; Yoshida M; Kimura M; Kinoshita K Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma. Mao Y; Wan X; Chen Y; Lv W; Xie X Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142 [TBL] [Abstract][Full Text] [Related]
15. Sparing fertility in young patients with endometrial cancer. Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267 [TBL] [Abstract][Full Text] [Related]
16. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Seong SJ; Kim TJ; Kim JW; Kim SM; Bae DS; Nam JH Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814 [TBL] [Abstract][Full Text] [Related]
17. Preserving fertility before assisted reproduction in women with endometrial carcinoma: case report and literature review. Gurgan T; Bozdag G; Demirol A; Ayhan A Reprod Biomed Online; 2007 Nov; 15(5):561-5. PubMed ID: 18028748 [TBL] [Abstract][Full Text] [Related]
18. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women]. Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458 [TBL] [Abstract][Full Text] [Related]
19. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246 [TBL] [Abstract][Full Text] [Related]
20. Continued medical treatment for persistent early endometrial cancer in young women. Cho A; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT Gynecol Oncol; 2021 Feb; 160(2):413-417. PubMed ID: 33246662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]